A Phase I Trial to Utilize Systems Biology Approaches to Examine the Safety, Immunogenicity, and 'Omics Response to MVA-BN-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Ad26 EBOV vaccine (Primary) ; Modified Vaccinia Ankara Bavarian Nordic Ebola Marburg vaccine (Primary)
- Indications Ebola virus infections; Marburg virus disease
- Focus Adverse reactions; Pharmacodynamics
- 18 Jan 2018 Planned primary completion date changed from 5 Jan 2018 to 15 Mar 2019.
- 18 Jan 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 24 Sep 2016 New trial record